SELUTION 4 De Novo Small Vessel IDE Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 960 participants.

Also called NCT05946629

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 960 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05946629
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Belgium, Germany (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05946629. Randomized; double masking; primary purpose treatment. Start 2023-10-20 (actual); primary completion 2027-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SELUTION 4 De Novo Small Vessel IDE Trial
Intervention (Device)
PCI (percutaneous coronary intervention) with SELUTION SLR DCB
Intervention (Device)
PCI with FDA approved "-limus" DES
Lead sponsor
M.A. Med Alliance S.A. (class: industry)
Collaborator
NAMSA (class: other)
Collaborator
Cordis US Corp. (class: industry)

Record details

Record id
cardio:ct-nct05946629
Content hash
a270c86d69d83e93438ee04d4f7ad08b8042a77499fe38b57945a09ef41a0a29